發泡的全球市場 2024-2028
市場調查報告書
商品編碼
1422558

發泡的全球市場 2024-2028

Global Effervescent Tablet Market 2024-2028

出版日期: | 出版商: TechNavio | 英文 159 Pages | 訂單完成後即時交付

價格

概述

預計 2023 年至 2028 年發泡錠劑將成長 48 億美元,預測期內複合年成長率為 8.36%。

該報告包括對發泡市場的整體分析、錠劑規模/預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的錠劑在老齡化人群中的日益普及、發泡相對於普通錠劑的優越性以及慢性病患病率的上升。

市場範圍
基準年 2024年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
2024年與前一年同期比較 7.84%
複合年成長率 8.36%
增量 48億美元

研究指出,青少年和兒童的發泡補充品的可用性是未來幾年推動發泡市場成長的關鍵因素之一。此外,有機發泡的開拓以及發泡線上上管道的日益普及導致了市場的巨大需求。

目錄

第1章執行摘要

  • 市場概況

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 細分市場分析
  • 2023 年市場規模
  • 2023-2028年市場展望

第4章 市場規模表現

  • 2018-2022年全球發泡錠劑
  • 2018-2022年通路細分分析
  • 2018-2022年類型細分分析
  • 2018-2022 年區域細分分析
  • 2018-2022 年國家細分分析

第5章五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第6章市場區隔:按分銷管道

  • 細分市場
  • 比較:按分銷管道
  • 醫院藥局:市場規模與預測 2023-2028
  • 零售藥局:市場規模與預測 2023-2028
  • 線上藥局:市場規模與預測 2023-2028
  • 市場機會:依分銷管道分類

第7章市場區隔:依類型

  • 細分市場
  • 比較:按類型
  • 處方箋:2023-2028年市場規模與預測
  • 商店:2023-2028 年市場規模與預測
  • 市場機會:按類型

第8章 客戶形勢

  • 客戶形勢概覽

第9章 地區形勢

  • 區域細分
  • 區域比較
  • 北美:2023-2028 年市場規模與預測
  • 歐洲:2023-2028 年市場規模與預測
  • 亞洲:2023-2028年市場規模與預測
  • 世界其他地區:2023-2028 年市場規模與預測
  • 美國:2023-2028 年市場規模與預測
  • 印度:2023-2028年市場規模與預測
  • 德國:2023-2028 年市場規模與預測
  • 日本:2023-2028年市場規模與預測
  • 英國:2023-2028 年市場規模與預測
  • 市場機會:依地區形勢

第 10 章 促進因素、挑戰與趨勢

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場趨勢

第11章 供應商形勢

  • 概述
  • 供應商形勢
  • 混亂的情況
  • 產業風險

第12章供應商分析

  • 交易廠商
  • 供應商市場定位
  • Alturix Ltd.
  • Bayer AG
  • Bliss GVS Pharma Ltd.
  • Bristol Myers Squibb Co.
  • CHIESI Farmaceutici SpA
  • GlaxoSmithKline Plc
  • HERMES PHARMA GmbH
  • Natur Produkt Zdrovit Sp ZOO
  • Nestle SA
  • Novartis AG
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • SG Biopharm Pvt. Ltd.
  • SciTech Specialities Pvt Ltd.

第13章附錄

Product Code: IRTNTR74506

Abstract

The effervescent tablet market is forecasted to grow by USD 4.80 bn during 2023-2028, accelerating at a CAGR of 8.36% during the forecast period. The report on the effervescent tablet market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of effervescent tablets among the aging population, the advantages of effervescent tablets over regular tablets, and the rising prevalence of chronic diseases.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.84%
CAGR8.36%
Incremental Value$4.80bn

Technavio's effervescent tablet market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Type

  • Prescription
  • Over the counter

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the availability of effervescent supplements for youth and children as one of the prime reasons driving the effervescent tablet market growth during the next few years. Also, development of organic effervescent tablets and increasing popularity of effervescent tablets on online channels will lead to sizable demand in the market.

The report on the effervescent tablet market covers the following areas:

  • Effervescent tablet market sizing
  • Effervescent tablet market forecast
  • Effervescent tablet market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading effervescent tablet market vendors that include Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories. Also, the effervescent tablet market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global effervescent tablet market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global effervescent tablet market 2018 - 2022 ($ billion)
  • 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.4 Retail pharmacy - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.5 Online pharmacy - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 46: Market opportunity by Distribution Channel ($ billion)
  • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 48: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
  • Exhibit 50: Chart on Comparison by Type
  • Exhibit 51: Data Table on Comparison by Type
  • 7.3 Prescription - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 54: Chart on Prescription - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
  • 7.4 Over the counter - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 58: Chart on Over the counter - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 60: Market opportunity by Type ($ billion)
  • Exhibit 61: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 India - Market size and forecast 2023-2028
  • Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 Japan - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
  • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 Alturix Ltd.
  • Exhibit 111: Alturix Ltd. - Overview
  • Exhibit 112: Alturix Ltd. - Product / Service
  • Exhibit 113: Alturix Ltd. - Key offerings
  • 12.4 Bayer AG
  • Exhibit 114: Bayer AG - Overview
  • Exhibit 115: Bayer AG - Business segments
  • Exhibit 116: Bayer AG - Key news
  • Exhibit 117: Bayer AG - Key offerings
  • Exhibit 118: Bayer AG - Segment focus
  • 12.5 Bliss GVS Pharma Ltd.
  • Exhibit 119: Bliss GVS Pharma Ltd. - Overview
  • Exhibit 120: Bliss GVS Pharma Ltd. - Business segments
  • Exhibit 121: Bliss GVS Pharma Ltd. - Key offerings
  • Exhibit 122: Bliss GVS Pharma Ltd. - Segment focus
  • 12.6 Bristol Myers Squibb Co.
  • Exhibit 123: Bristol Myers Squibb Co. - Overview
  • Exhibit 124: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 125: Bristol Myers Squibb Co. - Key news
  • Exhibit 126: Bristol Myers Squibb Co. - Key offerings
  • 12.7 CHIESI Farmaceutici SpA
  • Exhibit 127: CHIESI Farmaceutici SpA - Overview
  • Exhibit 128: CHIESI Farmaceutici SpA - Product / Service
  • Exhibit 129: CHIESI Farmaceutici SpA - Key offerings
  • 12.8 GlaxoSmithKline Plc
  • Exhibit 130: GlaxoSmithKline Plc - Overview
  • Exhibit 131: GlaxoSmithKline Plc - Business segments
  • Exhibit 132: GlaxoSmithKline Plc - Key news
  • Exhibit 133: GlaxoSmithKline Plc - Key offerings
  • Exhibit 134: GlaxoSmithKline Plc - Segment focus
  • 12.9 HERMES PHARMA GmbH
  • Exhibit 135: HERMES PHARMA GmbH - Overview
  • Exhibit 136: HERMES PHARMA GmbH - Product / Service
  • Exhibit 137: HERMES PHARMA GmbH - Key offerings
  • 12.10 Natur Produkt Zdrovit Sp Z O O
  • Exhibit 138: Natur Produkt Zdrovit Sp Z O O - Overview
  • Exhibit 139: Natur Produkt Zdrovit Sp Z O O - Product / Service
  • Exhibit 140: Natur Produkt Zdrovit Sp Z O O - Key offerings
  • 12.11 Nestle SA
  • Exhibit 141: Nestle SA - Overview
  • Exhibit 142: Nestle SA - Business segments
  • Exhibit 143: Nestle SA - Key news
  • Exhibit 144: Nestle SA - Key offerings
  • Exhibit 145: Nestle SA - Segment focus
  • 12.12 Novartis AG
  • Exhibit 146: Novartis AG - Overview
  • Exhibit 147: Novartis AG - Business segments
  • Exhibit 148: Novartis AG - Key offerings
  • Exhibit 149: Novartis AG - Segment focus
  • 12.13 Perrigo Co. Plc
  • Exhibit 150: Perrigo Co. Plc - Overview
  • Exhibit 151: Perrigo Co. Plc - Business segments
  • Exhibit 152: Perrigo Co. Plc - Key news
  • Exhibit 153: Perrigo Co. Plc - Key offerings
  • Exhibit 154: Perrigo Co. Plc - Segment focus
  • 12.14 Pfizer Inc.
  • Exhibit 155: Pfizer Inc. - Overview
  • Exhibit 156: Pfizer Inc. - Product / Service
  • Exhibit 157: Pfizer Inc. - Key news
  • Exhibit 158: Pfizer Inc. - Key offerings
  • 12.15 Reckitt Benckiser Group Plc
  • Exhibit 159: Reckitt Benckiser Group Plc - Overview
  • Exhibit 160: Reckitt Benckiser Group Plc - Business segments
  • Exhibit 161: Reckitt Benckiser Group Plc - Key offerings
  • Exhibit 162: Reckitt Benckiser Group Plc - Segment focus
  • 12.16 S. G. Biopharm Pvt. Ltd.
  • Exhibit 163: S. G. Biopharm Pvt. Ltd. - Overview
  • Exhibit 164: S. G. Biopharm Pvt. Ltd. - Product / Service
  • Exhibit 165: S. G. Biopharm Pvt. Ltd. - Key offerings
  • 12.17 SciTech Specialities Pvt Ltd.
  • Exhibit 166: SciTech Specialities Pvt Ltd. - Overview
  • Exhibit 167: SciTech Specialities Pvt Ltd. - Product / Service
  • Exhibit 168: SciTech Specialities Pvt Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 169: Inclusions checklist
  • Exhibit 170: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 171: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 172: Research methodology
  • Exhibit 173: Validation techniques employed for market sizing
  • Exhibit 174: Information sources
  • 13.5 List of abbreviations
  • Exhibit 175: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global effervescent tablet market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Distribution Channel ($ billion)
  • Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
  • Exhibits48: Chart on Type - Market share 2023-2028 (%)
  • Exhibits49: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by Type
  • Exhibits51: Data Table on Comparison by Type
  • Exhibits52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Prescription - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on Over the counter - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Market opportunity by Type ($ billion)
  • Exhibits61: Data Table on Market opportunity by Type ($ billion)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits105: Impact of drivers and challenges in 2023 and 2028
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: Alturix Ltd. - Overview
  • Exhibits112: Alturix Ltd. - Product / Service
  • Exhibits113: Alturix Ltd. - Key offerings
  • Exhibits114: Bayer AG - Overview
  • Exhibits115: Bayer AG - Business segments
  • Exhibits116: Bayer AG - Key news
  • Exhibits117: Bayer AG - Key offerings
  • Exhibits118: Bayer AG - Segment focus
  • Exhibits119: Bliss GVS Pharma Ltd. - Overview
  • Exhibits120: Bliss GVS Pharma Ltd. - Business segments
  • Exhibits121: Bliss GVS Pharma Ltd. - Key offerings
  • Exhibits122: Bliss GVS Pharma Ltd. - Segment focus
  • Exhibits123: Bristol Myers Squibb Co. - Overview
  • Exhibits124: Bristol Myers Squibb Co. - Product / Service
  • Exhibits125: Bristol Myers Squibb Co. - Key news
  • Exhibits126: Bristol Myers Squibb Co. - Key offerings
  • Exhibits127: CHIESI Farmaceutici SpA - Overview
  • Exhibits128: CHIESI Farmaceutici SpA - Product / Service
  • Exhibits129: CHIESI Farmaceutici SpA - Key offerings
  • Exhibits130: GlaxoSmithKline Plc - Overview
  • Exhibits131: GlaxoSmithKline Plc - Business segments
  • Exhibits132: GlaxoSmithKline Plc - Key news
  • Exhibits133: GlaxoSmithKline Plc - Key offerings
  • Exhibits134: GlaxoSmithKline Plc - Segment focus
  • Exhibits135: HERMES PHARMA GmbH - Overview
  • Exhibits136: HERMES PHARMA GmbH - Product / Service
  • Exhibits137: HERMES PHARMA GmbH - Key offerings
  • Exhibits138: Natur Produkt Zdrovit Sp Z O O - Overview
  • Exhibits139: Natur Produkt Zdrovit Sp Z O O - Product / Service
  • Exhibits140: Natur Produkt Zdrovit Sp Z O O - Key offerings
  • Exhibits141: Nestle SA - Overview
  • Exhibits142: Nestle SA - Business segments
  • Exhibits143: Nestle SA - Key news
  • Exhibits144: Nestle SA - Key offerings
  • Exhibits145: Nestle SA - Segment focus
  • Exhibits146: Novartis AG - Overview
  • Exhibits147: Novartis AG - Business segments
  • Exhibits148: Novartis AG - Key offerings
  • Exhibits149: Novartis AG - Segment focus
  • Exhibits150: Perrigo Co. Plc - Overview
  • Exhibits151: Perrigo Co. Plc - Business segments
  • Exhibits152: Perrigo Co. Plc - Key news
  • Exhibits153: Perrigo Co. Plc - Key offerings
  • Exhibits154: Perrigo Co. Plc - Segment focus
  • Exhibits155: Pfizer Inc. - Overview
  • Exhibits156: Pfizer Inc. - Product / Service
  • Exhibits157: Pfizer Inc. - Key news
  • Exhibits158: Pfizer Inc. - Key offerings
  • Exhibits159: Reckitt Benckiser Group Plc - Overview
  • Exhibits160: Reckitt Benckiser Group Plc - Business segments
  • Exhibits161: Reckitt Benckiser Group Plc - Key offerings
  • Exhibits162: Reckitt Benckiser Group Plc - Segment focus
  • Exhibits163: S. G. Biopharm Pvt. Ltd. - Overview
  • Exhibits164: S. G. Biopharm Pvt. Ltd. - Product / Service
  • Exhibits165: S. G. Biopharm Pvt. Ltd. - Key offerings
  • Exhibits166: SciTech Specialities Pvt Ltd. - Overview
  • Exhibits167: SciTech Specialities Pvt Ltd. - Product / Service
  • Exhibits168: SciTech Specialities Pvt Ltd. - Key offerings
  • Exhibits169: Inclusions checklist
  • Exhibits170: Exclusions checklist
  • Exhibits171: Currency conversion rates for US$
  • Exhibits172: Research methodology
  • Exhibits173: Validation techniques employed for market sizing
  • Exhibits174: Information sources
  • Exhibits175: List of abbreviations